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Abstract 
 
Cervical cancer is one of the leading causes of death among women around the 
world and is linked to the human papillomavirus (HPV). Strains HPV-16 and-18 are 
linked to the causes of cervical cancer. Research shows that HPV vaccination in 
adolescent females projects a 70% non-contraction rate.  However, only 57.3% of girls 
between the ages of 13-17 in the U.S. have received their first HPV vaccination dose.  
Researchers have begun speculating that factors such SES and race could be contributing 
to low vaccination participation. Answers to such information can aid in improving 
federal and state vaccination policies and prevent the diseases caused by HPV. The 
current study aimed to determine if race and socioeconomic status (SES) interacted in 
such a way that predicted the attitudes of minority caregivers toward the HPV vaccine in 
terms of its acceptability and accessibility. Parents of adolescent females enrolled at a 
local Mississippi high school were surveyed to determine if this interaction predicts lower 
vaccination rates. It was anticipated that minority parents of low SES would have lower 
vaccination rates than those of higher SES.  The univariate results indicated the 
following: 90% of participants identified as African American/Black, 39% (majority) of 
the respondents had completed some college or obtained an associate’s degree, 42%  
(majority) of the income level was between $30,001-$50,000, and 70% of daughters had 
received some shots of the HPV vaccination. Bivariate Chi-Square (𝑋2) analyses 
determined if categorical independent variables (Race, Education, and Finances) were 
significantly associated with vaccine participation. Bivariate tests were not statistically 
significant (p> 0.05). However, a correlation between vaccination participation and 
income showed that the higher the income level, the more likely a parent was to vaccinate 
 v 
their daughter against HPV. Other independent variables yielded significance. At the 
univariate level, 74% of health care providers had recommended the vaccine, 72% of 
respondents had insurance to cover vaccine, and 70% of respondents had very easy 
access to health care. At the bivariate level, only two independent variables were 
significant. The results showed the following: insurance coverage: (95 % CI: (1.038-
20.3810) (𝑋2 = 4.353, 𝐷𝑓 = 1, 𝑎𝑛𝑑 𝑆𝑖𝑔 𝑝 = 0.037) and vaccine recommendation (95% 
CI: 3.675-156.738) (𝑋2 = 14.727, 𝐷𝑓 = 1, 𝑎𝑛𝑑 𝑆𝑖𝑔 𝑝 = 0.0001).  Being recommended 
by a health care provider was a significant predictor of vaccine participation at the 
multivariate level. Ostensibly, parents are aware of the vaccine and are taking preventive 
measures. Additional research could answer whether minority caregivers from low SES 
will be less inclined to have their adolescent daughters vaccinated. HPV is one of the 
most preventive, yet deadly, STIs and further research is imperative.  
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Chapter 1: Introduction  
Cervical cancer is one of the leading causes of death among women around the 
world that is caused primarily from sexual contact.  The human papillomavirus (HPV) is 
a sexually transmitted virus that at least half of sexually active men and women will 
contract. Strains HPV-16 and-18 are linked to the causes of cervical cancer that are 
responsible for 4,000 annual fatalities. Recent studies suggest that HPV vaccination in 
adolescent females between the ages of 9-16 (before sexual activity initiation), projects a 
70% non-contraction rate.  However, only 57.3% of girls between the ages of 13-17 in 
the United States have received the first HPV vaccination dose.  
Researchers speculate that outside factors such as class and race contribute to low 
participation in HPV vaccination. Class and race play vital roles in the vaccination of 
young female adults because of increasing health care costs. To further investigate these 
findings, parents/guardians of high school adolescent females from the Hattiesburg area 
completed a Likert scale survey. The purpose of this study was to determine how race 
and socioeconomics status (SES) interact in such a way that minority parents with low 
SES are more apprehensive about giving their adolescent daughters vaccine due to the 
lack of health education and physician accessibility.  Results were assembled and 
analyzed appropriately.  
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Chapter 2:  Literature Review  
In 1956, a group of researchers from several countries discovered human 
papillomavirus (HPV) ( Roxas). Little is known about the initial discovery and the 
researchers responsible. However, in 1972, female Polish dermatologist Stefania 
Ginsburg-Jabłońska discovered the link between skin cancer and HPV (Kibbe, 2012). It 
was not until the 1980s that HPV DNA was found in genital lesions and HPV-16 and -18 
were extracted from the cervix by German virologist Harald zur Hausen (Aronowitz, 
Epstein, Livingston, & Wailoo, 2010). zur Hausen went on to win the Nobel Peace Prize 
in Medicine in 2008 for his 1976 research and is credited with discovering the link 
between HPV and cervical cancer (Aronowitz, Epstein, Livingston, & Wailoo, 2010).  
HPV is a sexually transmitted virus infection (STI) that currently affects 20 
million people in the United States (The Centers for Disease Control and Prevention, 
2012). At least 50% of all sexually active males and females will contract HPV at some 
point in their lifetimes (Food and Drug Administration Office of Women’s Health, 2015). 
By definition, these viruses are known as papilloma because they have the ability to 
cause genital warts or benign tumors (American Cancer Society, 2014). These papilloma 
viruses reside in epithelial cells (cells that are located on the skin and moist surfaces of 
the body) that can be found on surfaces of the vagina, anus, cervix, trachea, eyelids, and 
other moist parts of the body (American Cancer Society, 2014). Unlike human 
immunodeficiency virus (HIV), which is an infection found in the bodily fluids of an 
infected person, HPV is a virus that affects the skin and moist membrane linings. Humans 
are susceptible to HPV contraction through vaginal, anal, and or oral sexual contact with 
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an infectious person. HPV has no cure, but there are vaccines that can prevent the viral 
infection (The Centers for Disease Control and Prevention, 2011).  
According to the Centers for Disease Control and Prevention (2013), 110 million 
people in the U.S. are infected with an STI and approximately 20 million new infections 
surface yearly that cost $16 billion in national medical expenditures. A 2013 report 
released by the CDC states “that HPV accounts for the majority of newly acquired STIs” 
(The Centers for Disease Control and Prevention, 2013). The CDC estimates that HPV 
cases make up 14,100,000 (90%) new STI cases in the U.S. and young people between 
the ages of 15-24 make up half of those incident cases (The Centers for Disease Control 
and Prevention, 2013). 
Unlike STIs such as gonorrhea, HPV is asymptomatic. Thus, thousands of cases 
go undiagnosed annually. The National Cancer Institute (2012) suggests that 42.5 percent 
of women have genital HPV infections, whereas fewer than 7% of adults have oral HPV 
infections at any point in time. Contraction of HPV increases if sexual activity begins at 
an early age or if a young person (ages between 9-26) has polygamous sexual 
relationships (The National Cancer Institute, 2012). Besides sexual skin contact, the odds 
of HPV contraction increase if one smokes, has HIV or any other immune system 
deficiency, uses birth-control for more than five years, or has three or more children 
(Food and Drug Administration Office of Women's Health , 2015). Most HPV strains 
resolve without intervention, while others cause genital warts, which present as soft 
growths on the skin and mucus membranes of the genitals. With over 150 strains of HPV, 
only types 16 and 18 are known to be carcinogenic (American Cancer Society, 2014). 
Strains 16 and 18 have been of significant interest because they are linked to cervical 
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cancer, which is one of the most fatal cancers among women in the United States 
(American Cancer Society, 2014).  
In order to understand the link between cervical cancer and HPV, the origin and 
areas affected by cervical cancer must be thoroughly explained. Cancer is a disease in 
which cells divide abnormally. Regions in which those cells grow irregularly are given 
names based on their bodily location. Cervical cancer is a disease that originates within 
the cervix of a female. The cervix connects the vagina to the uterus in the female organ 
system. Cervical cancer is caused from HPV strains 16 and 18 (The Centers for Disease 
Control and Prevention, 2012). Detection of this disease comes from annually scheduled 
Papanicolaou smear tests (Pap Test) that identify cancerous cells on the cervix, or HPV 
tests which detect the virus itself. Early signs and symptoms are rare but they can include 
abnormal or bleeding discharge from the vagina (The Centers for Disease Control and 
Prevention, 2012). If HPV is contracted, cervical cancer can take 10-20 months to fully 
develop. As the third leading type of cancer among women in the United States, 
approximately 12,000 cases are diagnosed each year (American Cancer Society, 2014). 
The American Cancer Society (2014) suggests that in 2015, 4,100 women will die from 
cervical cancer. Eighty-five percent of the women diagnosed with cervical cancer will be 
younger than 65, with Blacks and Hispanics having higher rates (American Cancer 
Society, 2015).  
As previously stated, in 1976 Harald zur Hausen discovered the link between 
cervical cancer and HPV. However, it was not until June of 2006 that the Food and Drug 
Administration (FDA) approved Merck & Co., Inc.’s distribution of the Gardasil Human 
Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant to prevent 
 5 
infection with the two most commonly occurring strains of HPV that cause cervical 
cancer and the two most commonly occurring strains of HPV that cause genital warts. 
(Aronowitz, Epstein, Livingston, & Wailoo, 2010). According to the National Institutes 
of Health, the FDA has approved Gardasil for use in females for the prevention of 
cervical cancer and some vulvar and vaginal cancers caused by HPV types 16 and 18, and 
for use in males and females for the prevention of anal cancer and precancerous anal 
lesions caused by HPV types 16 and 18 (The National Cancer Institute, 2012). Gardasil is 
one of two vaccines known to prevent strains 6, 11, 16, and 18. The other vaccine is 
GlaxoSmithKline's Cervarix, and it is only known to prevent HPV strains 16 and 18. 
Gardasil is injected into muscle tissue in a series of three doses over a six-month period. 
It is highly recommended by physicians and health agencies for adolescents (male and 
female) before they become sexually active. This vaccine is recommended for non-
pregnant women between the ages of 9-26.  
Since becoming available in 2006, an estimated 70% of cervical cancer cases 
among those who received the complete vaccination series were prevented (The Centers 
for Disease Control and Prevention, 2011). The earlier a young person receives the 
vaccination, the less susceptible he or she is to contract the viral strains linked to cervical 
cancer. However, while Merck’s Gardasil vaccine made strides with regard to cancer 
prevention and STI treatment, its cost sparked controversy. At $350 per dose in 2007, 
Merck & Co., Inc. had the monopoly on the Gardasil vaccine because they were the only 
company distributing it (Aronowitz, Epstein, Livingston, & Wailoo, 2010). Thus, they 
had almost complete control over the cost and distribution. Costs for Gardasil in 2006, 
which at this point had become known as a preventive “cancer drug,” drew closer 
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attention to the United States’ “haves and have-nots” (Aronowitz, Epstein, Livingston, & 
Wailoo, 2010). In other words, the cost of this vaccine illuminated economic disparities 
between those who could and could not afford it.  
In April of 2014, the American Cancer Society estimated that the price of 
Gardasil ranged from $130 to $140 per dose with the total cost being $360 not including 
the cost of the physician visit (American Cancer Society, 2014). This was a significant 
reduction from the $350 per dose cost that was charged before the 2010 Patient 
Protection and Affordable Care Act (PPACA or Affordable Health Care Act), which 
mandated that “plans and issuers are required to provide coverage without cost-sharing 
for this service exactly” (U.S. Department of Health & Human Services, 2012). This 
means that health and insurance companies cannot share the cost of the vaccine but must 
choose whether or not to pay for health fees. Although costs of the vaccination series 
have been reduced since 2006, currently the cost is $360 per vaccination series per person 
(American Cancer Society, 2014).   
It is important to consider this issue of cost from a socioeconomic standpoint. The 
American Psychological Association defines socioeconomic status (SES) as the 
following:  
Socioeconomic status (SES) is often measured as a combination of education, 
income, and occupation. It is commonly conceptualized as the social standing or 
class of an individual or group. When viewed through a social class lens, 
privilege, power, and control are emphasized. Furthermore, an examination of 
SES as a gradient or continuous variable reveals inequities in access to and 
distribution of resources (American Psychological Association, 2015).  
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The U.S. Census Bureau stated that in 2012 the average income family earnings 
(family of four) based on socioeconomic class were as follows: lower class at $23,050, 
lower middle class between $32,500 and $60,000, upper middle class at $100,000, and 
the upper class at $250,000 (Francis, 2012), The average American family of four in 
2014 spent $23,215 on healthcare with an average employer sponsored health plan 
(Milliman, 2014). Costs more than doubled in 2014 over 2004 when the average family 
spent just $11,192 (Milliman, 2014). With the median household income at $51, 939, 
almost half of the average American family’s earnings is spent on healthcare for families 
with average insurance plans (Milliman, 2014). This income ratio as it relates to SES 
limits health care access to certain groups that fall within the lower and middle class 
income levels. Ostensibly, over the past 50 years, medicine’s ability to increase the 
quality of life and life expectancy has illustrated the gap between those who do and do 
not have access to health care in the United States (Swartz, 2009).  
It is evident that the relationship between income and healthcare cost for average 
Americans is non-proportional and that this ratio is the result of health disparities among 
specific groups such as minorities. The Centers for Disease Control (2014) defines 
minorities as Asian American, Black or African American, Hispanic or Latino, Native 
Hawaiian and Other Pacific Islander, American Indian and Alaska Native. In 2013, the 
average income of minorities was $33,901 (DeNavas-Walt & Proctor, 2014). In that same 
year, the income level among Whites was $55,257 (DeNavas-Walt & Proctor, 2014). 
Average minorities fall into the lower class and lower middle class based on their 
earnings. Because of this, average minority households do not have easy access to 
healthcare, primarily because they cannot afford it. For example, a study published by the 
 8 
United States Bureau of Labor Statistics (2014) analyzed the average income of African 
American households, and found that the average income in an African American 
household was $45,287. Of that income, $1,794 was spent on healthcare (Noël, 2014). It 
is plausible to infer that the low income of average minorities affect how much they 
spend on healthcare. On average, minorities fall into a socioeconomically deprived class 
that cannot afford healthcare. As a domino effect, this situation deprives minorities of 
health education, which is part of the reason they do not receive vaccinations.  
In order to fully understand how SES impacted the accessibility of the Gardasil 
vaccine to minority groups, it is necessary to examine what began to transpire in the 
United States economically at the time of Gardasil’s initial distribution and how that 
relates to socioeconomic disparities. The National Bureau of Economic Research stated 
that in December of 2007, the United States along with other countries around the world 
began to experience the Great Recession. This led to the loss of 8.9 million jobs across 
the country between 2007 and 2010. Minorities were among those most affected by this 
recession. Pew’s Research Center reports: 
From 2005 to 2009, inflation-adjusted median wealth fell by 66% among 
Hispanic households and 53% among black households, compared with just 16% 
among white households. As a result of these declines, the typical black 
household had just $5,677 in wealth (assets minus debts) in 2009; the typical 
Hispanic household had $6,325 in wealth; and the typical white household had 
$113,149. Worse, 35% of African Americans and 31% of Hispanics reported zero 
or negative net worth in 2009. By contrast, only 15% of white households were in 
the same boat (Taylor, Kochhar, Fry, Velasco, & Motel, 2011). 
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Because of the loss of jobs and the net worth among minorities during this great 
recession, many lost access to affordable health insurance. Access to health services 
diminished and the consideration of risking savings on a new expensive vaccine was 
unlikely. The 16% of white households that were affected, compared to the 66% of 
African Americans and 53% of Hispanic households that were affected, illustrates who 
was excluded from Merck’s vaccine during its initial distribution stages due to cost. Non-
minority groups had better access to health care services because only a small percentage 
of their household populations was affected. Thus, they were more likely to receive the 
vaccination because they could afford it. Because of this monopoly and the country’s 
economic crisis, some minorities of low socioeconomic status were financially excluded 
from obtaining Gardasil.  
Attempts to indirectly remedy the problem of Gardasil’s cost only furthered the 
problem for these minority groups. In late 2006, 26 state legislatures across the United 
States began to produce legislation that required the vaccine to be received by middle 
school girls (Aronowitz, Epstein, Livingston, & Wailoo, 2010). Of these 26 states, 22 
state legislative bodies rejected the Gardasil mandate (Aronowitz, Epstein, Livingston, & 
Wailoo, 2010). Many legislators, conservative organizations, and concerned 
parents/guardians viewed the Gardasil mandate as healthcare socialism while some 
viewed it as a positive governmental intervention that benefited the health of its citizens. 
Only the District of Columbia and Virginia passed legislation mandating the vaccine. 
Despite the fact that Texas rejected these mandates, Texas Governor Rick Perry went as 
far as issuing an executive order to mandate the vaccine (Aronowitz, Epstein, Livingston, 
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& Wailoo, 2010). Perry’s use of governmental authority was overruled and no laws were 
implemented.  
In the midst of these proposed mandates, the question of cost began to surface, 
including who would cover the cost and what type of economic burden this would place 
on the average American family. In 2013 (eight years since the beginning of these 
mandates), only eight states provided funding for this vaccine (The Henry J. Kaiser 
Family Foundation, 2013). This left the other 42 states’ citizens to rely upon federal, 
private, and employment based insurance to compensate for the cost. This burden of cost 
continues to increase for average lower and working class citizens, especially when 
health insurance companies opt out of covering the vaccine’s cost.  
 This problem of cost is most prevalent among those who are socioeconomically 
disadvantaged. In this way, HPV vaccination can be viewed as both a health care issue 
and a socioeconomic problem that targets specific social classes in each state. The state 
of Mississippi is a clear representation of the socioeconomic disparity attached to HPV 
vaccination. The issues that Mississippi faces regarding HPV vaccination revolve around 
the fact that HPV vaccination is not accepted by or accessible to those with low SES and 
minority racial groups.  
 Mississippi is composed of 59.8% Whites, 37.4% of Blacks/African Americans, 
and 2.8% Asian, Hispanic or Latino Americans (U.S. Census Bureau, 2014). In 2014, the 
average income of Mississippians was $39,031 (U.S. Census Bureau, 2014), making it 
the poorest state in America. Today, 22.7% of Mississippians are below the poverty level 
in comparison to the national average of persons below poverty level, which is 15.7% 
(U.S. Census Bureau, 2014). Minorities in Mississippi are the most socioeconomically 
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disadvantaged group of individuals in the state. For example, the household income of 
Blacks in 2006, “was $21,969 or just 51% that of white households ($43,139)” (Hill, 
2008). This study on the Economic Status of Blacks in the State of Mississippi 
highlighted the economic disparity between racial groups and how those who come from 
a lower SES background suffer (Hill, 2008).  
The majority of Mississippians from low SES backgrounds also lives in 
impoverished communities. As a result they only have access to substandard education. 
To understand how Mississippi’s impoverished communities affect education, it is 
important to explore national correlations between poverty and education.  
More than one in five U.S. children live in “official” poverty today, with an even 
higher rate for Black and Hispanic children and for those in families headed by a 
single parent. Among the world’s 35 richest countries, the United States holds the 
distinction of ranking second highest in child poverty. A large body of research 
continues to document the negative effects of poverty on children and their later 
life outcomes. Children growing up in poverty complete less schooling, work and 
earn less as adults, are more likely to receive public assistance, and have poorer 
health (Coley & Baker, 2013). 
Twenty-two percent of children in the U.S. live in poverty (National Center for Children 
in Poverty (NCCP), 2014). Statistically, these national trends have placed not only a 
strain on the U.S. economy, but also they continue to jeopardize the health education of 
its citizens. Predictably, Mississippi’s correlations between poverty and education fall 
below the national trends. Thirty-two percent of children in Mississippi live in poverty 
(National Center for Children in Poverty (NCCP), 2014). Of that 32%, child minorities 
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are the most impoverished. Columbia University researchers at the National Center for 
Children in Poverty (2014) estimate that “49% of Blacks and 40% of Hispanics in 
Mississippi are impoverished while only 17% of Whites fall into that category.” This 
relates to education because the higher the average poverty rate, the less likely one is to 
attend college (The Pell Institute for the Study of Opportunity in Higher Education, 
2015). Overall, this decline in the ability to climb the educational ladder limits their 
knowledge and access to health education because they cannot afford education let alone 
healthcare. Inadequate health education and access increase in Mississippi as poverty 
continues to increase. Limited health education and access to health care increases the 
risk for impoverished Mississippians to develop health problems. 
In 2014, Mississippi ranked last in overall health (United Health Foundation, 
2014). Mississippi currently has the second highest sexually transmitted infection (STI) 
rate in the U.S., including but not limited to HIV, gonorrhea, trichomoniasis, syphilis, and 
HPV. Despite the fact that it ranks among the highest in incidence rates for STIs, it has 
one of the lowest budgets for overall health. Furthermore, Mississippi only allocates 
$1,354,661 in preventive funding (The Henry J. Kaiser Family Foundation, 2013).  
In 2014 Mississippians had a 78.5% preventable hospitalization rate (United 
Health Foundation, 2014). According to the United Health Foundation, immunization 
among young adults (who make up half the amount of new STI/STD rates) could have 
significantly decreased this hospitalization rate. Mississippi is ranked 11th in the country 
for child immunization (United Health Foundation, 2014). Although 74.6% of children 
ages 1-12 in Mississippi are immunized, only 45.2% of adolescents between the ages of 
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13-27 are immunized (United Health Foundation, 2014) . This leaves Mississippi with an 
overall state adolescent immunization ranking of 50 (United Health Foundation, 2014).  
 As previously noted, HPV makes up 90% of newly acquired STI infections in the 
United States. HPV, like most STIs, is a preventable disease. Its contraction rate and the 
amount of hospitalizations associated with HPV could be significantly decreased if 
vaccination was more prevalent in Mississippi. No laws, governing policies, funding, or 
mandates regarding the HPV vaccinations have been implemented in Mississippi (The 
Henry J. Kaiser Family Foundation, 2015). Mississippi is one of ten states in which fewer 
than 30% of adolescents (between the ages of 13-17) have received the HPV vaccination 
(The Henry J. Kaiser Family Foundation, 2015).  
Nationally, socioeconomic hardship has proven to be one of the primary reasons 
why parents are not having their adolescent sons and daughters vaccinated against HPV. 
This, along with lack of education about the vaccine, seems to play a major role in why 
minority individuals from a low SES background are not having their children vaccinated 
in southern Mississippi. The current study focuses on determining if race and 
socioeconomic status (SES) interact in such a way that will predict the attitudes of 
minority caregivers toward the HPV vaccination, in terms of its acceptability and 
accessibility. It is presumed that minority caregivers in Mississippi from a low SES will 
be less inclined to have their adolescent daughters vaccinated due to their lack of 
education about the vaccine as well as their inability to afford the vaccine. 
 Parents of guardians of adolescent females enrolled at Hattiesburg High School 
in Hattiesburg, Mississippi, were surveyed to determine if this interaction predicted lower 
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vaccination rates. This population was chosen because HPV is responsible for cervical 
cancer fatalities among women and adolescent females and because Mississippi women 
have a higher cervical cancer contraction rate than the national average (Mississippi State 
University, 2010). This population was also chosen because the Hattiesburg area has an 
increasing STI incidence rate (Frelix, 2009). Understanding this relationship is important 
because it answers questions regarding how parents in Mississippi feel about the HPV 
vaccine. Such information could have implications for health policies at both the state 
and federal levels that could help to improve vaccination policies and prevent the 
diseases caused by HPV. 
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Chapter 3: Methodology   
Participants  
Participants were 18 years of age or older and were the current parent/guardian of 
an adolescent female at Hattiesburg High School.  
Measures 
A 22-item questionnaire was distributed to all parents/guardians of Hattiesburg 
High School students in order to examine the extent to which race and SES influence 
parental attitudes toward the HPV vaccination of adolescent females. Most questions 
were answered on a 5-point Likert scale. Items were adapted from a survey used in a 
study conducted by Reiter et al. (2009) regarding parental attitudes toward the HPV 
vaccine. 
Procedure 
 Before distributing the questionnaire, permission was sought from both the 
superintendent’s office of the Hattiesburg Public School District and the principal of 
Hattiesburg High School. Upon receiving approval, the principal of Hattiesburg High 
School distributed an anonymous survey link via email to all parents/guardians of 
Hattiesburg High School students. This survey was administered using the web-based 
Qualtrics survey system. Responses were immediately uploaded to the Qualtrics system 
and remained completely anonymous. The survey remained open for two weeks.  
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Chapter 4: Results and Discussion  
Experimental Results  
On the first attempt, a survey was sent via email to a total of 1,053 
parents/guardians at Hattiesburg High School. On the second attempt, the survey was 
emailed to a total of 1,114 parents/guardians at Hattiesburg High School. A total of 60 
respondents completed the survey. Only 43 of the 60 respondents answered whether their 
child had received any shots of the HPV vaccination. Of those 43 participants, 90% of 
them identified as Black (Figure 1). Most of the respondents had completed some college 
or obtained an associate’s degree (Figure 2). The majority income level of respondents 
was between $30,001-$50,000 (Figure 3). More than half of the respondents answered 
“Yes” to their adolescent daughter receiving the HPV Vaccination (Figure 4) and 
provided reasons why (Figure 5 and Figure 6). Once these univariate descriptive statistics 
were examined, bivariate Pearson Chi-Square (𝑋2) analyses were conducted to determine 
if categorical independent variables were significantly associated with vaccine 
participation (Table 1). The results of all hypothesis driven analyses were non-significant. 
However, a general correlation was observed between income level and vaccine 
participation (Table 2). Results show that the higher the income of the respondent, the 
more likely parents were to vaccinate their adolescent daughters against HPV.  
Exploratory Results 
Some univariate results also proved to be of significance. Figure 7 shows that 
74% of healthcare providers recommended the vaccine. Figure 8 shows that 94% of the 
respondent’s insurance covered the vaccine. Although the hypothesized data were not 
statistically significant, additional bivariate analysis produced results that were 
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statistically significant (Table 1). Because of these findings, a logistic regression analysis 
was conducted to model the relationship between independent and dependent variables. 
Those independent variables found to be significantly associated with vaccine 
participation at the bivariate level were included in the multivariate model (Table 2). The 
only independent variable that remained statistically significant during the logistic 
regression was the question regarding vaccine recommendation by health care providers 
(95% CI: 3.675-156.738) (𝑋2 = 14.727, 𝐷𝑓 = 1, 𝑎𝑛𝑑 𝑆𝑖𝑔 𝑝 = 0.0001) (Table 2).  
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Experimental Tables and Figures 
 
Figure1. Race of Survey Respondents  
 
Figure 2. Education of Survey Respondents  
90%
10%
Race of Survey Respondents 
(N=43)
Black
White
9%
39%
26%
26%
Education of Survey Respondents 
(N=43) 
High School
Diploma or Less
Some college or
associates degree
BS degree
Anything above
BS
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Figure 3. Income of Survey Respondents  
 
Figure 4. HPV Vaccination  
25%
42%
19%
14%
Income of Survey Respondents
(N=43)
$0-$30,000
$30,001-$50,000
$50,001-$80,000
$80,001 and
above
Unemployed
70%
30%
HPV Vaccination 
(N=43)
Yes
No
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Figure 5. Reasons to Vaccinate Against HPV Provided by Parents of Adolescent Daughters 
  
 
Figure 6. Reasons Not to Vaccinate Against HPV Provided by Parents of Adolescent 
Daughters  
  
 
 
 
 
 
82%
7%
11%
Reasons to Vaccinate Against HPV Provided by Parents of 
Adolescent Daughters
(N=43)
To Prevent
Cervical Cancer
Daughter is at
High Risk for
Cervical Cancer
Other
23%
23%
7%
8%
8%
8%
23%
Reasons Not to Vaccinate Against HPV Provided by Parents of 
Adolescent Daughters
(N=43) Never Heard of
the Vaccine
Need More
info/don't know
enough about it
Vaccine too new
Vaccine unsafe
Daughter is too
Young
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Table 1.  Bivariate Results for Race, Education, and Financial (N=43) 
Table 1.  Bivariate Results for Race, Education, and Finances (N=43) 
 
 
 
 
 
Table 2. Bivariate Results for Income (N=43) 
Has your daughter 
had any shots of 
the HPV Vaccine? 
$0-$30,000 $30,001-$50,000 $50,001-$80,000 $80,001- and 
above 
Yes 4 11 7 4 
No 5 4 0 1 
Total 9 15 7 5 
 
 
 
 
 
 
 
 
 
 
Independent 
Variable  
Category (N=43) Percent 
Vaccinated  
Chi-Square 
Tests 
Value  Df Asymp. 
Sig.  
(2-sided) 
Race Black (37) 70.30% Pearson 
Chi-Square 
1.612 2 0.447 
Education  Some College or 
Associates Degree 
(17) 
64.70% Pearson 
Chi-Square 
1.751 3 0.626 
Financial  $30,001-$50,000 (15)  73.30% Pearson 
Chi-Square 
6.878 5 0.230 
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Exploratory Figures and Tables 
 
Figure 7: Vaccine Recommendation 
 
 
Figure 8. Vaccine Insurance Coverage 
74%
26%
Vaccine Recommendation
(N=43)
Yes
No
72%
28%
Vaccine Insurance Coverage
(N=43)
Yes
No
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Figure 9. Health Care Accessibility (N=43) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
30%
70%
Health Care Accessibility
(N=43)
Somewhat
Easy &Easy
Very Easy
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Table 3. Bivariate Results for Exploratory Analysis (* indicates significance) 
 
 
Table 4. Multivariate Regression of Vaccine Recommendation (* indicates significance) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Independent 
Variables  
Category 
(N=43) 
Percent 
Vaccinated 
Chi-Square 
Tests  
Value Df Asymp. Sig 
(2-sided) 
HPV 
Insurance 
Coverage  
Yes (28) 82.1% Pearson Chi-
Square 
4.353 1
1 
0.037* 
Health Care 
Access 
Very 
Easy (28) 
78.6% Pearson Chi-
Square 
3.265 1
1 
0.071* 
Health Care 
Recommenda
tion  
Yes (28) 85.7% Pearson Chi-
Square 
14.72
7 
1
1 
0.0001* 
Step 𝟏𝒂 Df Sig Exp (B) 95% C.I. 
Lower 
95% C.I. 
Higher 
Q22 Recode: 
Vaccine 
Recommendation  
1 0.001* 24.000 3.675 156.738 
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Chapter 5: Conclusion  
 
Experimental Conclusion  
Examining how race and SES interact to determine how minority 
parents/guardians with low income feel toward vaccinating their adolescent daughters 
against HPV did not yield the expected results. The literary analysis concludes that 
minority parents of low SES are more unlikely to vaccinate their children against HPV. 
This lack of vaccination participation is reportedly due to a lack of educational and 
financial means regarding vaccination (Coley & Baker, 2013). In the current study, the 
data do not support those described in the literature pertaining to vaccination, race, and 
SES.  Approximately 90% of the survey respondents were Black and 70% of the 
respondents’ adolescent daughters had received at least some shots of the vaccine. While 
the majority of respondents had some college education but made no more than $50,000 a 
year, a majority of their daughters still received some, if not all, shots of the vaccine 
series. These descriptive statistics illustrate how minorities of low SES are not entirely 
apathetic toward HPV vaccination. At the univariate level, these results suggest that 
parents/guardians are aware of the HPV vaccine and are pursuing preventive measures to 
protect their daughters. No differences between white or black, rich or poor, influenced 
whether or not parents/guardians vaccinated their daughters against HPV. This finding 
could be due to a small respondent pool.  
At the bivariate level, the hypothesized analysis did not yield significant results. 
The Pearson Chi-Square test was used to determine if there was a significant association 
between vaccination participation and key categorical variables. An analysis of the 
association between race and HPV participation yielded a Pearson Chi-Square test 𝑋2 =
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1.612, 𝐷𝑓 = 2, 𝑎𝑛𝑑 𝑆𝑖𝑔 𝑝 = 0.447. Analysis of the association between educational 
level and HPV participation yielded a Pearson Chi Square of 𝑋2 = 1.751, 𝐷𝑓 =
3, 𝑎𝑛𝑑 𝑆𝑖𝑔 𝑝 = 0.626. Analysis of the association between income before taxes and HPV 
participation yielded a Pearson Chi-Square of 𝑋2 = 6.878, 𝐷𝑓 = 5, 𝑎𝑛𝑑 𝑆𝑖𝑔 𝑝 = 0.230. 
Because no association was found (p ≤ 0.05) between any of the above variables pairs, 
multivariate inferential statistics were not conducted. This lack of a significant 
association showed that SES (education and finances) and race had no significant 
relationship to HPV vaccination participation. This lack of significance between 
vaccination participation and Race and SES could be due to the lack of a large 
respondents population. Although these results yielded no significant relationships, a 
correlation was noticed between income and vaccination participation (Table 2). The 
percentage of respondents vaccinating their daughters rose for each increasing income 
bracket. In the first category 44.4% were vaccinated, in the second income bracket 73.3% 
were vaccinated and in the highest income bracket 80% were vaccinated. As income 
increases, vaccination rates increase. This trend supports the findings in other studies that 
suggest that the higher the income level, the more likely one is to vaccinate their daughter 
against HPV (Coley & Baker, 2013).   
 
Exploratory Conclusion  
While the hypothesized data did not yield significance at the bivariate level, other 
independent variables did yield interesting results. At the univariate level, 74% of health 
care providers had recommended the vaccine, 72% of respondents also had insurance to 
cover vaccine, and 70% of respondents had very easy access to health care. At the 
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bivariate level, all of these independent variables showed a significant association with 
vaccine participation (p ≤0.05). Those who had insurance coverage were 4.6 times more 
likely to be vaccinated than those who did not have coverage or were unaware if their 
insurance companies covered the vaccine (95 % CI: (1.038-20.3810) (𝑋2 = 4.353, 𝐷𝑓 =
1, 𝑎𝑛𝑑 𝑆𝑖𝑔 𝑝 = 0.037). Those who found it vey easy to find a doctor, health care 
provider, or clinic to access were 3.67 times more likely to get the vaccine, but these 
results were not significant (95% CI: 0.862-15.593) (𝑋2 = 3.265, 𝐷𝑓 = 1, 𝑎𝑛𝑑 𝑆𝑖𝑔 𝑝 =
0.071). Because this relationship was nearly significant, this variable was included in the 
multivariate analysis. Participants whose doctor or healthcare provider recommended the 
vaccine were 24 times more likely to be vaccinated than those not recommended (95% 
CI: 3.675-156.738) (𝑋2 = 14.727, 𝐷𝑓 = 1, 𝑎𝑛𝑑 𝑆𝑖𝑔 𝑝 = 0.0001). These three variables 
that were found to be significantly associated at the bivariate level (p< 0.10) were 
analyzed using forward stepwise linear regression. After the analysis was completed, 
only being recommended to vaccination by a health care provider was a significant 
predictor of vaccine participation (p<0.005) (Exploratory Tables and Figures: Table 2).  
There is a 95% confidence that the general populations of people who are recommended 
to get the vaccine are 3.675- 156.738 times more likely to do so. While this 95% 
confidence is an accurate representation of the population, those receiving vaccination 
based on recommendation, these values are not precise. This large range in the 
confidence interval bounds could be due to the lack of respondents. 
Limitations  
 A majority of the results found were limited to a lack of survey respondents. Only 
60 respondents completed the survey, but only 43 of those 60 respondents were used. 
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Low participation in this study could be due to a lack of incentives to complete the 
survey, summer-break, or lack of access to technology. If there were incentives such as a 
gift card, raffle, etc., parents could have been more likely to respond. However, if these 
incentives had been in place, it could have jeopardized the confidentiality of the survey 
by linking the survey to the respondents. Summer-break could have been a deterrent of 
study participation. Students at Hattiesburg High School were out of school during the 
release of the survey, thus parents/guardians could have been less inclined to participate 
in a study that was not during the school year. Access to technology is another drawback 
of study participation. Many parents/guardians may be older and not be technologically 
savvy, or they could have not had access to the survey. All of these factors could have 
contributed to a lack of survey participation. If the number of survey respondents was 
increased, it is probable that the hypothesized and exploratory results would have 
projected more significant findings.  
Ostensibly, it is evident that parents/guardians are aware of the HPV vaccine and 
are taking measures to protect their daughters against HPV. The hypothesized analysis 
did not yield significance, but it did project a trend between income levels and 
vaccination. Thus, allowing one to conclude that there is some correlation between SES 
and HPV vaccination participation. The exploratory analysis did yield significant results 
at both the bivariate and multivariate levels, thus showing that parents/guardians are more 
likely to get their daughters vaccinated if there is very easy access, doctor 
recommendations, and vaccine coverage. 
 Because the largest limitation of this study is lack of participation, the results can 
only be discussed as preliminary findings. Further research efforts should focus on 
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increasing participation among parents in order to assess if race and SES variables are 
significantly associated with HPV vaccination participation. The only way to determine if 
these outcome values interact significantly with each other is by increasing respondent 
participation. Additional research to this preliminary analysis could answer the unknown 
question as to whether or not minority caregivers in Mississippi from a low SES will be 
less inclined to have their adolescent daughters vaccinated due to their lack of education 
about the vaccine as well as their inability to afford the vaccine. Additional research 
could also lead to HPV cost reform. Because HPV is one of the most preventive, yet 
deadly STIs amongst women in the United States, further research is imperative.  
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Appendix B:  
 
Participant Permission Letter 
 
Dear Prospective Participant, 
  My name is Kristen Dupard, and I am a student-researcher from the University of 
Southern Mississippi. I am conducting an anonymous survey about parent’s/guardian’s 
attitudes on accessibility and acceptability of HPV vaccination in adolescent females. 
This study is important because it will begin to answer unknown questions of how 
parents in Mississippi feel about HPV vaccination for their adolescent daughters; thus, 
trying to develop policy guidelines for HPV education and vaccination. To participate in 
this study, you must be 18 years or older and be the parent/ guardian of an adolescent 
female that currently attends Hattiesburg High School.  If you have more than one 
adolescent daughter at Hattiesburg High School, please complete this survey for each 
one. This survey is strictly voluntary and will remain completely anonymous. There are 
no benefits or other incentives that will be provided to you or your adolescent daughter if 
you choose to complete this survey. Some questions in this survey below are sensitive in 
nature and may ask for personal information. Some risks for participating in this survey 
include: asking about personal information regarding your adolescent daughter’s 
vaccination information, your income information, your gender, and your race. All 
participation in this study is voluntary, and has been approved by the Institutional Review 
Board (IRB) at the University of Southern Mississippi. All data compiled from this 
survey via the Qualtrics system will be destroyed once the data is collected and analyzed.  
The survey will take 5-15 minutes to complete. Please answer all questions to 
your comfort level. In addition, you may choose not to answer any questions that make 
you uncomfortable. Remember, your participation in this survey is completely 
anonymous. The results will be reported for the group of respondents as a whole, and no 
individual names or specific individual information will be released. This study is 
voluntary in nature, and you can choose whether or not to participate after reading this 
information letter.   
  For more information regarding the survey or for any unforeseen circumstances 
due to survey malfunction, uncomfortably, or any other inquires please contact the 
following individual: 
 Dr. Ray G. Newman                                                             
Phone: 601-266-5435                                                            
Email: ray.newman@usm.edu. 
  
 Thank you for your consideration. 
 
Sincerely, 
 Kristen Dupard 
 
 If you would like to begin the survey, select the ">>" tab in the bottom right hand corner 
below. 
 
If you choose not to continue, please exit out of this window.   
